Bausch Health’s Bausch + Lomb Gets Canada OK for Glaucoma Treatment

Bausch + Lomb, part of Bausch Health (BHC), said Thursday that Health Canada issued a notice of compliance for Vyzulta for the treatment of glaucoma.

Vyzulta is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

https://www.marketscreener.com/BAUSCH-HEALTH-COMPANIES-I-44965076/news/Bausch-Health-Lomb-Gets-Canadian-Approval-for-Glaucoma-Treatment-27818120/